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A B S T R A C T
Objectives: Examine the association of genetic polymorphisms with age at menarche (AAM) in Russian women.
Study design: A total of 1613 Russian females were recruited for the study.
Fifty two polymorphisms were analyzed for their association with AAM, height, and BMI.
The associations were analyzed assuming the additive, dominant, and recessive models and using the log-
linear regression as implemented in PLINK v. 2.050. The 2-, 3-, and 4-loci models of gene-gene interactions were
analyzed using the MB-MDR method and validated by the permutation test.
Main outcome measures: Genetic polymorphism rs6438424 3q13.32 was independently associated with AAM in
Russian women. In addition, 14 SNPs were determined as possible contributors to this trait through gene-gene
interactions.
Results: The obtained results suggest that 14 out of 52 studied polymorphisms may contribute to AAM in Russian
women. The rs6438424 3q13.32 polymorphism was associated with AAM according to both additive and
dominant models (рperm= 0.005). In total 12 two-, three-, and four-locus models of gene-gene interactions were
determined as contributing to AAM (pperm≤ 0.006). Nine of the 14 AAM-associated SNPs are also associated
with height and BMI (pperm≤0.003). Among 14 AAM-associated SNPs (a priori all having regulatory sig-
nificance), the highest regulatory potential was determined for rs4633 COMT, rs2164808 POMC,
rs2252673INSR, rs6438424 3q13.32, and rs10769908 STK33. Eleven loci are cis-eQTL and affect expression of
14 genes in various tissues and organs (FDR < 0.05).
The neuropeptide-encoding genes were overrepresented among the AAM-associated genes (pbonf= 0.039).
Conclusions: The rs6438424 polymorphism is independently associated with AAM in Russian females in this
study. The other 14 SNPs manifest this association through gene-gene interactions.
1. Introduction
Age at menarche (AAM) is one of the important characteristics of
the pubertal development and marks a beginning of the reproductive
period. AAM is controlled by the hypothalamic–pituitary–ovarian axis
and associated with female fertility and possible health complications
in the later life. Early menarche may increase a risk for obesity (Guo
and Ji, 2011), uterine myoma (Wise and Laughlin-Tommaso, 2016),
endometriosis (Nnoaham et al., 2012), breast cancer (Yermachenko and
Dvornyk, 2014), cardiovascular diseases (Feng et al., 2008), type 2
diabetes mellitus, infertility and psychological problems (Yermachenko
and Dvornyk, 2014).
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AAM has significant between-ethnic variation (Yermachenko and
Dvornyk, 2014). The variation in AAM was reported between popula-
tions of the same ethnicity too. For example, the mean AAM in females
from South Europe (12.0–12.6 years) is lower than in the Northern
European countries (13.0–13.3 years) (Yermachenko and Dvornyk,
2014; Parent et al., 2003). Twin and family studies suggested that ge-
netic factors account up to 53–74% of AAM variance (Kaprio et al.,
1995). Several genome-wide association studies (GWAS) having con-
ducted so far determined over 100 polymorphisms, which might con-
tribute to the trait (He et al., 2009; Ong et al., 2009; Perry et al., 2009;
Sulem et al., 2009; Elks et al., 2010; Demerath et al., 2013; Perry et al.,
2014). However, the reproducibility of these results in various popu-
lations and ethnicities is low. For example, in a sample of 6269 Chinese
females, Delahanty et al. (Delahanty et al., 2013) confirmed association
with AAM of only 9 out of 37 single nucleotide polymorphism (SNPs)
previously reported by Elks et al. (Elks et al., 2010) in their GWAS.
Pyun et al. (Pyun et al., 2014) failed to reproduce association with AAM
of 42 SNPs from the GWAS by He et al. (He et al., 2010) in the Korean
sample of 3452 females. Out of 33 SNPs significantly associated with
AAM in women of the European ancestry (He et al., 2009; Ong et al.,
2009; Perry et al., 2009; Sulem et al., 2009; He et al., 2010), only two
were later confirmed in the sample of 15,000 Japanese females
(Tanikawa et al., 2013).
There is evidence that candidate genes for menarche (e.g., LIN28B,
FTO, TNNI3K, MAP2K5, FANCL, STK33, GPRC5B, POMC/RBJ and the
others) may also be associated with various anthropometric characters
(e.g., height, body mass index (BMI), and the others) and thus suggest a
common genetic basis for these traits (Ong et al., 2009; Elks et al., 2010;
Perry et al., 2014; Fernandez-Rhodes et al., 2013). Replication studies
are important for understanding a role of specific candidate genes for
AAM in populations of different ethnicity, history, and genetic struc-
ture. With reference to this, genetic factors for AAM in Russian females
have not been studied so far.
This article presents the results of a replication analysis of the
previously reported AAM-associated polymorphisms in Russian women.
In addition, several SNPs, which demonstrated non-significant asso-
ciations with AAM but were involved in the menarche-related pathways
(e.g., vitamin D metabolism, polycystic ovary syndrome, etc.), were
also analyzed for their association with AAM.
2. Material and methods
2.1. Study subjects
The participants were recruited through the Perinatal Centre of St.
Joasaph Belgorod Regional Clinical Hospital during 2009–2013. The
eligible participants were unrelated women of Russian descent (self-
declared) born in Central Russia (Rudyh and Sirotina, 2015). The fol-
lowing exclusion criteria were adopted: non-Russian descent, a birth-
place outside of Central Russia, malignant tumors of a small pelvis and
breast, chronic severe diseases of the vital organs (heart, respiratory or
renal failure), severe autoimmune diseases. The study was approved by
the Regional Ethics Committee of Belgorod State University. All parti-
cipants signed an informed consent prior to the enrolment to this study.
The information about AAM was obtained through the ques-
tionnaire. AAM was defined as an age (full years) of first menses. Each
participant was asked a question: “Your age of first menses - __ full
years?” Women with AAM≥18 years (n=7) or refusing to answer
(n=21) were excluded from the study. The anthropometric char-
acteristics were collected by standard methods: height was measured to
the nearest 0.1 cm using the portable stadiometer; weight was then
measured in an upright position, to the nearest 0.1 kg, using a cali-
brated balance beam scale. All participants were clinically examined for
presence of benign tumors and hyperplastic disorders of the re-
productive organs in women (leiomyoma, endometriosis, and en-
dometrial hyperplasia).
The study sample consisted in total of 1700 females, including 966
with various isolated or combined benign tumors and hyperplastic
disorders of the reproductive organs and 734 otherwise healthy.
2.2. Blood sample collection and DNA handling
Blood (5ml) was drawn by a certified nurse from the ulnar vein of
each participant to a plastic vial (Vacutainer®) containing 0.5M EDTA
solution (рН=8.0). Total genomic DNA was isolated from buffy coat
using the standard phenol-chloroform method and then checked for
quality using Nanodrop 2000 spectrophotometer (Thermo Scientific,
Inc.). Only samples with А260/А280=1.7–2.0 were included in the
analysis. The isolated DNA was stored at −80°С.
2.3. SNP selection
The 53 SNPs for the analysis were selected based on the following
criteria (Ponomarenko, 2018): 1) Previously reported associations with
AAM or traits having common biological pathways with menarche
(anthropometric characteristics, obesity, vitamin D metabolism, etc.),
2) Regulatory potential (regSNP), 3) Effect on gene expression (eSNP),
and 4) Tag value (tagSNP).
The regulatory potential of the SNPs and effect on gene expression
was estimated using the online tools HaploReg (v4.1) (http://archive.
broadinstitute.org/mammals/haploreg/haploreg.php), RegulomeDB
(Version 1.1) (http://regulome.stanford.edu/), rSNPBase (http://rsnp.
psych.ac.cn/index.do), SNPinfo Web Server – SNP Function Prediction
(FuncPred) (https://snpinfo.niehs.nih.gov/snpinfo/snpfunc.html),
Blood eQTL browser (http://genenetwork.nl/bloodeqtlbrowser/), and
GTExportal (http://www.gtexportal.org/).
The tagSNP values were determined using the SNPinfo Web Server
of the National Institute of Environmental Health Sciences (NIEHS) –
LD TAG SNP Selection (TagSNP) (https://snpinfo.niehs.nih.gov/
snpinfo/snptag.html) and the data from the International HapMap
(phase III) and dbSNP. The LD between SNP pairs was estimated as-
suming the maximum between-SNP distance of 250 kb and r2≥ 0.8
(± 10–20 kb and ± 500–700 kb at 5`- and 3`-end of a gene, respec-
tively).
The information about the selected SNPs is given in Supplementary
Table 1. All SNPs appear to have a significant regulatory potential
(Supplementary Table 2), 44 of them (83.02%) are eSNPs
(Supplementary Table 3), 30 are tagSNPs, 17 are associated with var-
ious anthropometric characteristics (Supplementary Table 4).
Out of the 53 selected SNPs, 14 were associated with AAM ac-
cording to the GWAS results (He et al., 2009; Ong et al., 2009; Perry
et al., 2009; Sulem et al., 2009; Elks et al., 2010; Demerath et al., 2013;
Perry et al., 2014) and 28 – according to the candidate gene association
studies (Delahanty et al., 2013; Pyun et al., 2014; He et al., 2010;
Tanikawa et al., 2013; Fernandez-Rhodes et al., 2013; Stavrou et al.,
2006) (Supplementary Table 4). In addition, 11 SNPs, which did not
demonstrated significant association with AAM, but were associated or
tag with the traits related to the menarche (e.g., vitamin D metabolism,
polycystic ovary syndrome development, anthropometric characters,
etc., Supplementary Table 4). These SNPs included rs1884051 ESR1,
rs3020394 ESR1, rs12324955 FTO, rs4633 COMT, rs11724758 FABP2,
rs222020 GC, rs222003 GC, rs1544410 VDR, rs3756261 EGF,
rs7766109 F13A1, rs2252673 INSR. All these SNPs have a significant
regulatory potential, ten of them are eSNPs and nine are tagSNPs.
2.4. SNP genotyping
DNA samples were genotyped using the Sequenom MassARRAY®
iPLEX platform, which is based on MALDI-TOF (matrix-assisted laser
desorption/ionization time-of-flight) mass spectrometry at the Centre of
Genomic Sciences, the University of Hong Kong. The analyzed DNA
samples had concentration 10–15 ng/ml. The MassARRAY® assay
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design software Assay Design Suite 1.0 (http://agenabio.com/assay-
design-suite-10-software) was used to create a single well iPLEX SNP
genotyping assay. For this purpose, 53 SNPs of interest were retrieved
from dbSNP of NCBI and imported according to their IDs to Assay
Design Suite 1.0. After completing the consecutive automatic steps, the
genotyping assay was successfully generated and tested for cross am-
plification.
2.5. Data quality control
Quality of the genotypic data was assessed according to the missing
call rate defined as a fraction of missing calls per SNP for all samples.
The MassARRAY® Typer 4.0 software was used for cluster analysis of
the genotype calls. All samples successfully passed the quality control
with the following parameters: SNPs with call rate > 80%, the success
rate of duplicate check > 99.5%, and the success rate of the blank
check > 90%. One SNP, rs11724758, did not pass the quality control
(call rate < 80%) and was excluded from the further analysis. The
individuals with the proportion of determined genotypes< 95% out of
the maximum possible number were also excluded from the analysis
(n= 87).
The final sample used in the analyses included 1613 female parti-
cipants (917 women with benign tumors and hyperplastic disorders of
the reproductive organs and 696 otherwise healthy women). The pro-
portion of the determined genotypes for the 52 SNPs was 98.86%. The
general characteristics of the study participants are given in Table 1.
2.6. Statistical analysis
Differences in means of AAM between the analyzed groups were
estimated by the Kruskal–Wallis test. All polymorphisms were checked
for their correspondence to the Hardy-Weinberg equilibrium (HWE)
using the chi-square test. Since the distribution of AAM, height, and
BMI values in the sample was not normal (according to the Shapiro-
Wilk test), they were transformed using the QQ-plot function in the R
programming environment.
Association between a SNP minor allele and AAM was analyzed
using log-linear regression assuming the three principal models (ad-
ditive, recessive, and dominant). The year of birth, presence of isolated
or combined benign tumors and hyperplastic disorders of the re-
productive organs in women were transformed into discrete variables
and used as covariates (four and eight classes, respectively, Table 2).
The correction for multiple comparisons was made using the adaptive
permutation test. The significance level was set at pperm < 0.01. For the
given sample size (n=1613), the expected detectable differences in
AAM were 0.13–0.29 year under the additive model, 0.21–0.30 year
under the dominant model, and 0.21–1.80 year under the recessive
model (at 80% power, ɑ=0.05 for 2-sided test). The haplotype blocks
were determined using the ‘confidence intervals’ algorithm at D' > 0.8
as implemented in Haploview v.4.2 (https://www.broadinstitute.org/
haploview/haploview). Statistical power for each SNP was computed
using Quanto 1.2.4 (http://hydra.usc.edu/gxe 2009). The association
analyses were conducted using the PLINK v. 2.050 software (available
at: http://zzz.bwh.harvard.edu/plink/).
The gene-gene interactions were analyzed for the two-, three-, and
four-locus models using MB-MDR (Model Based Multifactor
Dimensionality Reduction) (Calle et al., 2008; Calle et al., 2010) as
implemented in the namesake software (v. 2.6) for the R programming
environment. MB-MDR is a modification of MDR and makes it possible
to analyze gene-gene interactions with adjustment for covariates and
validation by the permutation test with 1000 permutations (Mahachie
et al., 2012). The significance level was set at pperm < 0.01. The gene-
gene interactions and their relative contribution to the total variance of
the trait within the 2-, 3-, and 4-locus models were visualized using the
MDR method (http://www.multifactordimensionalityreduction.org/),
as implemented in MDR v. 3.0.2 (http://sourceforge.net/projects/mdr).
2.6.1. Analysis of association of the AAM candidate genes with body size
Since the candidate genes for AAM were previously suggested to
contribute to height and weight characteristics of females (Ong et al.,
2009, Elks et al., 2010, Perry et al., 2014, Fernandez-Rhodes et al.,
2013 and others), we analyzed all studied SNPs for such association.
The BMI association analyses were conducted using age and hyper-
plastic disorders of the reproductive organs in women (see above) as
covariates.
2.6.2. Functional SNPs
The AAM-associated and strongly linked to them SNPs were ana-
lyzed for their functional significance (non-synonymous SNPs, reg-
ulatory potential, and eQTLs). The SNPs in strong linkage dis-
equilibrium (LD) (r2≥ 0.8) with the AAM associated ones were
determined using the online version of HaploReg (v4.1). The linkage
Table 1
Anthropometric characteristics of the participants.
Parameters X ± SD(min-max)/%(n)
n 1613
Age, yrs 39.53 ± 8.98 (18–77)
Age at menarche, yrs 13.32 ± 1.28 (9–17)
Proportion of the participants by relative age at
menarche, % (n)
Early (< 12 yrs) 6.32 (102)
Average (12–14 yrs) 79.85 (1288)
Late (> 14 yrs) 13.83 (223)
Height, m 1.65 ± 0.06 (1.48–1.99)
Weight, kg 72.33 ± 14.01 (42–132)
BMI, kg/m2 26.53 ± 5.03 (15.22–48.91)
Proportion of the participants by relative BMI, %
(n)
Underweight (< 18.50) 2.23 (36)
Normal weight (18.50–24.99) 42.96 (693)
Overweight (25.00–29.99) 31.06 (501)
Obese (> 30.00) 23.75 (383)
Table 2
Characteristics of age at menarche in the participants.





1930–1960 301 13.69 ± 1.38 <0.001
1961–1970 639 13.41 ± 1.18
1971–1980 505 13.11 ± 1.26
1981–1990 168 12.91 ± 1.34
Body mass index
Underweight (< 18.50) 36 13.33 ± 1.39 0.99
Normal weight (18.50–24.99) 693 13.33 ± 1.30
Overweight (25.00–29.99) 501 13.31 ± 1.25
Obesity (> 30.00) 383 13.31 ± 1.30
Presence of benign tumors and hyperplastic disorders of the reproductive organs
Isolated uterine leiomyoma 192 13.55 ± 1.39 0.04
Isolated endometriosis 103 13.07 ± 1.33
Isolated endometrial hyperplasia 167 13.22 ± 1.31
Combined uterine leiomyoma and
endometriosis
109 13.36 ± 1.26
Combined uterine leiomyoma and
endometrial hyperplasia
170 13.42 ± 1.30
Combined endometriosis and endometrial
hyperplasia




98 13.39 ± 1.23
No benign tumors and hyperplastic
disorders of the reproductive organs
696 13.26 ± 1.25
Р, level of significance according to the Kruskal-Wallis test.
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disequilibrium was estimated using the data of the European population
from the 1000 Genomes Project Phase.
Non-synonymous SNPs and their predictive potential were analyzed
using SIFT (http://sift.jcvi.org/).
2.6.3. Regulatory effects
The in silico analysis of the regulatory potential of the candidate
SNPs for AAM was conducted using HaploReg (v4.1) (http://archive.
broadinstitute.org/mammals/haploreg/haploreg.php), RegulomeDB
(Version 1.1) (http://regulome.stanford.edu/), rSNPBase (http://rsnp.
psych.ac.cn/index.do), and SNP Function Prediction (FuncPred)
(https://snpinfo.niehs.nih.gov/snpinfo/snpfunc.html). The possible
regulatory effects of polymorphisms in a strong linkage disequilibrium
(r2≥ 0.8) with the AAM associated SNPs were analyzed using
HaploReg (v4.1).
2.6.4. Expression QTLs
The effect of the candidate SNPs for AAM on gene expression level
(cis- and trans-eQTL) was estimated in peripheral blood using the data
from the Blood eQTL browser (http://genenetwork.nl/
bloodeqtlbrowser/), and in other organs and tissues using the
GTExportal data (http://www.gtexportal.org/) as of 25.08.2017. To
determine significant eQTLs, the False Discovery Rate (FDR) ≤0.05 was
applied. Likewise, eQTL values of SNPs in the strong LD (r2≥ 0.8) with
the AAM associated polymorphisms were estimated.
2.6.5. Pathway analyses
The functional significance of the candidate genes for AAM in the
various biological pathways was studied using the Gene Ontology
Portal tools available at http://geneontology.org. The results of mul-
tiple comparisons were adjusted with the Bonferroni test. The gene
interaction networks were constructed using GeneMANIA (version
3.5.0) available at http://genemania.org.
3. Results
3.1. Study participants characteristics
The mean AAM was 13.32 ± 1.28 years (Table 1) and depended on
the year of birth and presence of benign tumors and hyperplastic dis-
orders of the reproductive organs in women (Table 2). There was a clear
secular trend in AAM (р < 0.001). The largest mean AAM difference
(0.78 yr) was observed between the participants born in 1930–1960
and 1981–1990. The mean AAM was different also between women
with and those without the various reproductive pathologies
(р=0.04).
3.2. SNP association analysis
The data about the studied SNPs are given in (Ponomarenko
et al.,2018a). All polymorphisms had MAF > 5% and corresponded to
the HWE (рbonf < 0.001).
Polymorphism rs6438424 3q13.32 was associated with AAM ac-
cording to the additive (β=0.067 ± 0.024, р=0.005, рperm=0.005)
and dominant (β= 0.102 ± 0.037, р=0.006, рperm=0.005) models
(Table 3). The individuals with genotype CC had menarche at age
13.49 ± 1.28 years that is 0.17 year later then in individuals with
genotype AC (13.32 ± 1.28 years) and 0.33 year later than in in-
dividuals of the AA genotype (13.16 ± 1.29 years) (p= 0.002, Fig. 1).
The power of the additive model was 94.44% (differences in AAM
per allele ≥0.16 year), and of the dominant one 83.85% (the AAM
difference between genotypes AC/CC and AA was 0.21 year,
p= 0.004). None of the haplotypes showed significant association with
AAM (Ponomarenko et al., 2018a).
3.3. SNP×SNP interactions
In total 12 significant gene-gene interactions affecting AAM were
determined for the 2-, 3-, and 4-locus models (Table 4). Out of the 14
SNPs involved in the models, rs7579411 LHCGR and rs1073768 GHRH
contributed to the largest number of the models (seven and six, re-
spectively). Polymorphisms rs6438424 3q13.3 and rs7759938 LIN28B
contribute to the models at all levels studied (2-, 3-, and 4-locus).
Three polymorphisms of the LIN28B gene (rs7759938, rs314276,
rs4946651) contributed to the most significant gene-gene interactions
affecting AAM (in total 6 of the 12 models). Genotypic combinations
associated with AAM according to the 12 significant models are given in
(Ponomarenko et al., 2018a). The most significant association were
determined for the following combinations: rs2252673 GG
INSR×rs4946651 GG LIN28B (beta=−1.029, p=0.00007),
rs1073768 GA GHRH×rs12617311 GA PLCL1×rs4374421 TT
LHCGR (beta=−0.324, p= 0.00003), rs6438424 AA
3q13.32×rs1073768 GA GHRH×rs4633 TT COMT×rs7579411 CC
LHCGR (beta=−1.116, p=0.00003).
The gene-gene interactions among 14 SNPs, which are included in
the best gene-gene interaction models associated with AAM, are vi-
sualized in Fig. 2. Despite the large number of the existing interactions,
the contribution of any of them to the trait was quite modest. The
largest value did not exceed 0.39%.
3.4. Association of the candidate genes for AAM with body size
Anthropometric characteristics of the participants are given in
(Ponomarenko et al., 2018a). The older individuals had a higher BMI
(p < 0.001). The participants with isolated endometriosis, isolated
endometrial hyperplasia, and combined endometriosis and endometrial
hyperplasia had the lowest BMI (25.15–25.88), while those with iso-
lated uterine leiomyoma, combined uterine leiomyoma, endometriosis
and endometrial hyperplasia had the highest BMI (27.95–28.10)
(p < 0.001). The mean height in all age groups was not significantly
different (p > 0.09).
Fifteen polymorphisms were associated with BMI within 11 sig-
nificant multilocus models of gene-gene interactions (Ponomarenko
et al., 2018a). The specific genotype combinations are given in
(Ponomarenko et al., 2018a). Neither SNPs nor haplotypes were in-
dividually associated with BMI (рperm > 0.01).
Sixteen polymorphisms were associated with height within 13 sig-
nificant multilocus models of gene-gene interactions (Ponomarenko
et al., 2018a). None of the SNPs or haplotypes was individually asso-
ciated with height (рperm > 0.01).
In summary, among the 14 AAM-associated polymorphisms, six
SNPs were associated with height and six – with BMI (Supplementary
Table 5). Three SNPs (rs12617311 PLCL1, rs1073768 GHRH и rs4633




None of the AAM-associated SNPs was replacement. However, one
of these SNPs, rs4633, was linked (r2= 0.99) to rs4680, which results
in a Val/Met replacement in the COMT protein. This amino acid change
has SIFT Score= 0.02 that corresponds to the predictive value “dele-
terious” (i.e., ≤0.05).
3.5.2. Regulatory effects
The results of the in silico analysis of the regulatory potential ac-
cording to the five databases are given in Supplementary Table 2. The
most pronounced effects were determined for rs4633 COMT; the sig-
nificant regulatory potential was suggested for rs2164808 POMC,
rs2252673INSR, rs6438424 3q13.32 and rs10769908 STK33.
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In addition, we analyzed 329 polymorphisms, which were linked
(r2≥ 0.8) to the 14 AAM-associated SNPs (Ponomarenko et al., 2018b).
Among those, three SNPs (one nonsynonymous and two synonymous)
were located in exons, one in 5′-UTR, 156 in introns, and 183 in in-
tergenic regions. Eighteen SNPs were located in evolutionarily con-
served regions.
Several SNPs of these appeared to have significant regulatory po-
tential (Ponomarenko et al., 2018b). For example, rs7766336 (linked to
rs7759938 and rs314276 of LIN28B) has a promoter histone mark in 19
tissues, is located in a DNase-1 hypersensitive region in 13 tissues, a
binding region for four regulatory, and a region of 19 regulatory motifs.
Polymorphism rs5878829 linked to the above mentioned SNPs
(r2= 0.98 и r2= 0.95, respectively) is located in the region of 30
regulatory motifs.
The AAM-associated rs4946651 LIN28B is strongly linked to
rs11754600 (r2= 0.95), which has a histone mark in 24 tissues and is
located in a DNase-1 hypersensitive region in 13 tissues, a binding re-
gion for two regulatory proteins, and a region of 13 regulatory motifs
(Ponomarenko et al., 2018b).
The significant regulatory potential was also detected for several
SNPs strongly linked (r2≥0.8) to the AAM-associated SNPs
(Ponomarenko et al., 2018b). These SNPs manifested their regulatory
effects in organs and tissues, which are pathogenetically important for
menarche: brain, ovaries, adipose tissue, liver, fetal adrenals, and others.
Table 3
Associations of the 52 SNPs with age at menarche.
Chr SNP n Additive model Dominant model Recessive model
β SE Р β SE Р β SE Р
1 rs1514175 1607 −0.011 0.024 0.638 0.001 0.034 0.980 −0.044 0.046 0.346
1 rs466639 1608 0.030 0.036 0.402 0.053 0.040 0.191 −0.175 0.136 0.198
1 rs7538038 1606 −0.030 0.029 0.314 −0.044 0.034 0.198 0.024 0.085 0.781
2 rs713586 1605 0.012 0.024 0.629 0.005 0.036 0.885 0.030 0.043 0.483
2 rs2164808 1609 0.012 0.024 0.616 0.011 0.038 0.774 0.022 0.041 0.590
2 rs7589318 1604 0.041 0.026 0.116 0.053 0.034 0.112 0.046 0.059 0.438
2 rs4374421 1548 0.019 0.026 0.473 0.034 0.035 0.321 −0.003 0.056 0.956
2 rs7579411 1593 0.032 0.024 0.176 0.015 0.036 0.685 0.081 0.042 0.055
2 rs6729809 1541 0.022 0.026 0.398 0.024 0.035 0.489 0.040 0.057 0.486
2 rs4953616 1598 0.021 0.027 0.431 0.038 0.034 0.262 −0.017 0.064 0.796
2 rs6732220 1604 −0.026 0.028 0.341 −0.028 0.034 0.413 −0.052 0.071 0.465
2 rs4953655 1606 −0.032 0.028 0.255 −0.037 0.034 0.276 −0.047 0.072 0.517
2 rs887912 1529 −0.003 0.029 0.903 0.016 0.035 0.641 −0.098 0.075 0.189
2 rs12617311 1605 0.008 0.025 0.758 −0.009 0.034 0.781 0.060 0.054 0.266
3 rs6438424 1594 0.067 0.024 0.005 0.102 0.037 0.006 0.076 0.040 0.058
4 rs2013573 1607 0.015 0.032 0.634 0.006 0.036 0.856 0.126 0.114 0.269
4 rs13111134 1608 0.020 0.029 0.488 0.022 0.034 0.521 0.035 0.083 0.675
4 rs222003 1609 0.022 0.047 0.640 0.026 0.048 0.585 −0.120 0.302 0.692
4 rs222020 1609 0.011 0.037 0.755 0.017 0.040 0.665 −0.058 0.156 0.708
4 rs3756261 1597 0.027 0.046 0.553 0.030 0.047 0.533 −0.011 0.276 0.968
5 rs757647 1591 0.041 0.028 0.149 0.046 0.034 0.180 0.066 0.076 0.380
6 rs7766109 1608 0.031 0.024 0.203 0.026 0.038 0.493 0.058 0.041 0.156
6 rs4946651 1610 0.017 0.024 0.476 0.013 0.035 0.703 0.038 0.045 0.401
6 rs7759938 1607 0.032 0.027 0.239 0.042 0.034 0.212 0.029 0.065 0.658
6 rs314280 1588 0.008 0.025 0.758 0.007 0.035 0.839 0.015 0.047 0.754
6 rs314276 1560 0.039 0.026 0.132 0.051 0.034 0.134 0.047 0.059 0.431
6 rs3020394 1608 0.047 0.026 0.067 0.036 0.034 0.287 0.133 0.058 0.022
6 rs1884051 1610 0.039 0.026 0.138 0.035 0.033 0.301 0.093 0.059 0.119
6 rs7753051 1607 −0.007 0.026 0.805 −0.002 0.034 0.950 −0.029 0.062 0.643
7 rs1079866 1608 −0.002 0.031 0.949 0.000 0.036 0.995 −0.021 0.097 0.829
8 rs2288696 1606 −0.031 0.031 0.309 −0.044 0.035 0.211 0.028 0.100 0.776
9 rs2090409 1516 −0.018 0.026 0.493 −0.013 0.036 0.722 −0.044 0.051 0.393
9 rs10980926 1601 0.008 0.026 0.743 0.021 0.034 0.533 −0.020 0.058 0.733
9 rs10441737 1558 0.001 0.026 0.967 0.008 0.034 0.807 −0.019 0.058 0.746
11 rs10769908 1585 0.007 0.024 0.768 0.009 0.038 0.808 0.010 0.041 0.810
11 rs555621 1607 0.054 0.025 0.030 0.074 0.035 0.036 0.062 0.047 0.188
11 rs11031010 1588 0.027 0.037 0.463 0.035 0.042 0.395 −0.016 0.139 0.905
11 rs1782507 1602 −0.028 0.025 0.272 −0.034 0.034 0.320 −0.038 0.051 0.454
11 rs6589964 1609 −0.020 0.024 0.389 −0.039 0.038 0.299 −0.014 0.040 0.721
12 rs1544410 1601 −0.009 0.024 0.721 −0.014 0.034 0.686 −0.007 0.047 0.886
14 rs999460 1607 0.020 0.025 0.431 0.039 0.034 0.247 −0.008 0.053 0.877
14 rs4986938 1608 0.021 0.025 0.402 0.058 0.034 0.087 −0.045 0.052 0.385
15 rs2241423 1600 0.006 0.031 0.839 0.033 0.036 0.354 −0.181 0.096 0.061
16 rs12444979 1601 −0.031 0.034 0.354 −0.029 0.038 0.451 −0.107 0.120 0.372
16 rs9939609 1606 0.018 0.024 0.456 0.006 0.036 0.872 0.049 0.043 0.251
16 rs12324955 1607 −0.005 0.026 0.862 −0.007 0.034 0.833 −0.001 0.062 0.984
18 rs1398217 1596 −0.038 0.025 0.131 −0.054 0.036 0.136 −0.040 0.045 0.374
19 rs2252673 1602 −0.048 0.030 0.107 −0.048 0.035 0.167 −0.109 0.086 0.207
20 rs1073768 1607 0.012 0.024 0.620 0.013 0.038 0.728 0.019 0.041 0.644
22 rs4633 1609 0.025 0.024 0.281 0.031 0.038 0.422 0.037 0.039 0.337
23 rs5930973 1589 0.043 0.050 0.390 NA NA NA NA NA NA
23 rs3092921 1608 0.011 0.044 0.803 NA NA NA NA NA NA
The results were obtained by the linear regression analysis with adjustment for covariates (year of birth, benign tumors and hyperplastic disorders of the reproductive
organs in women).
β, coefficient of the linear regression (change of the transformed age at menarche per minor allele).
SE, standard error.
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3.5.3. Expression QTLs
Three AAM-associated loci (rs2164808, rs1073768, and rs4633)
were found to affect significantly (p < 5×10−5, FDR < 0.05) the
mRNA expression level of some genes (DNAJC27,MANBAL, and COMT)
in peripheral blood (cis-eQTL) (Ponomarenko et al., 2018b). In addi-
tion, two of these SNPs are in strong LD with the other cis-eQTL SNPs
affecting mRNA expression in peripheral blood: rs2164808 is linked to
rs4665765 (r2= 0.99), which affects expression of DNAJC27
(p= 4.5×10−5, FDR=0.02), and rs4633 is linked to rs4680
(r2= 0.99) which affects expression of COMT (p= 1.9×10−5,
FDR=0.01). No trans-eQTL SNPs were determined (FDR > 0.05).
According to the data of the Genotype-Tissue Expression (GTEx)
Project, 9 out of the 14 AAM-associated SNPs are cis-eQTLs, i.e., sig-
nificantly associated (p < 8×10−5, FDR≤0.05) with the expression
level of 12 genes in various tissues and organs (Ponomarenko et al.,
2018b).
The most notable associations were determined for allele C of
rs6438424 (alt), which appears to increase expression of RP11-384F7.2
in the visceral fat (β=0.41, р=3.5×10−6, FDR≤0.05) and the
adrenal glands (β=0.70, р=1.5×10−11, FDR≤0.05), and LSAMP
(β=0.74, р= 6.3× 10−13, FDR≤0.05) in the adrenal glands.
Polymorphism rs10769908 had the highest cis-eQTL value and was
associated with the expression level of STK33 in five tissues and
TRIM66 in three tissues (Ponomarenko et al., 2018b).
Eight of the 14 AAM-associated SNPs were in strong LD (r2≥ 0.8)
with> 200 SNPs significantly (p < 8.5×10−5, FDR≤0.05) asso-
ciated with the mRNA expression in various tissues (Ponomarenko
et al., 2018b). Specifically, rs10769908 is linked (r2≥ 0.8) to over 120
Fig. 1. Age at menarche depending on the genotypes of the rs6438424 3q13.32 locus, years.
Table 4
The most significant models of SNP-SNP interactions associated with AAM.
N Models of SNP× SNP interactions NH betaH WH NL betaL WL Pperm
Two-locus models (р < 1*10−4)
1 rs314276 LIN28B×rs7579411 LHCGR 2 0.345 15.94 1 −0.140 4.24 <0.001
2 rs6438424 3q13.32×rs7579411 LHCGR 2 0.245 13.83 2 −0.245 16.80 0.004
3 rs7759938 LIN28B×rs7579411 LHCGR 2 0.340 15.31 1 −0.115 3.02 0.004
4 rs2252673 INSR×rs4946651 LIN28B 1 0.146 3.14 1 −1.029 15.92 0.006
Three-locus models (р < 1*10−7)
1 rs6438424 3q13.32×rs1073768 GHRH×rs4374421 LHCGR 5 0.318 30.24 3 −0.269 22.31 <0.001
2 rs6438424 3q13.32×rs1073768 GHRH×rs7579411 LHCGR 5 0.375 28.74 2 −0.403 17.68 <0.001
3 rs1073768 GHRH×rs12617311 PLCL1×rs4374421 LHCGR 2 0.203 5.76 4 −0.365 30.52 <0.001
4 rs12617311 PLCL1×rs7759938 LIN28B×rs7579411 LHCGR 5 0.367 30.27 2 −0.189 7.03 0.001
Four-locus models (р < 1*10−12)
1 rs2090409 TMEM38B×rs1073768 GHRH×rs2164808 POMC×rs4633 COMT 5 0.458 22.20 9 −0.588 54.70 <0.001
2 rs6589964 BSX×rs1073768 GHRH×rs10769908 STK33×rs7759938 LIN28B 11 0.550 56.90 5 −0.540 23.33 <0.001
3 rs314276 LIN28B x rs12617311 PLCL1×rs2164808 POMC×rs7579411 LHCGR 10 0.579 52.67 5 −0.335 18.28 <0.001
4 rs6438424 3q13.32×rs1073768 GHRH×rs4633 COMT×rs7579411 LHCGR 9 0.525 42.91 10 −0.494 57.15 <0.001
The results were obtained using the MB-MDR method with adjustment for сovariates (year of birth, benign tumors and hyperplastic disorders of the reproductive
organs in women); NH, number of significant genotypic combinations associated with the late menarche; beta H, coefficient of the linear regression for significant
genotypic combinations associated with the late menarche (change of the transformed age at menarche); WH, the Wald test value for significant genotypic com-
binations associated with the late menarche; NL, number of significant genotypic combinations associated with the early menarche; beta L, coefficient of the linear
regression for significant genotypic combinations associated with the early menarche (change of the transformed age at menarche); WL, the Wald test value for
significant genotypic combinations associated with the early menarche; Pperm, P value for the permutation test (1000 permutations).
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Fig. 2. The interaction entropy graph of SNP-SNP interactions with AAM based on the multifactor dimensionality reduction (MDR) analysis. Positive values of
entropy indicate synergistic interactions while the negative values indicate redundancy. The polymorphisms are denoted by the chromosome number and rs SNP ID.
The red and orange colors denote strong and moderate synergism, respectively, brown color denotes the independent effect, green and blue colors denote moderate
and strong antagonism. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 3. The interaction networks of the candidate genes for age at menarche inferred using GeneMANIA (http://genemania.org). The candidate genes determined in
the present study are cross-shaded; the colored figures outline the SNP×SNP interactions within the 4-locus models obtained by the MB-MDR method.
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SNPs associated with the transcription level of the STK33 and TRIM66
genes in various tissues.
In addition, rs6438424 is in strong LD (r2≥ 0.8) with 8 SNPs, which
are associated with the expression levels of RP11-384F7.2 (visceral fat
and adrenals) and LSAMP (adrenals), rs4946651 – with 14 SNPs af-
fecting expression of LINC00577 in the brain, rs7759938 and rs314276
– with 12 SNPs affecting expression of HACE1 in EBV-transformed
lymphocytes, rs2090409 – with 25 SNPs that influence the SLC44A1
expression in the colon (Ponomarenko et al., 2018b).
Overall, 11 of the 14 AAM-associated loci had the cis-eQTL value
(affected expression of 14 genes): three SNPs were independently asso-
ciated with the mRNA expression levels, seven SNPs were both in-
dependently associated with the mRNA expression levels and linked to
other cis-eQTLs, one SNP is linked to polymorphisms with cis-eQTL value.
3.6. Pathway analyses
The in silico analysis of the functional significance was conducted
for the 10 AAM-associated genes (POMC, LHCGR, PLCL1, LIN28B,
TMEM38B, STK33, BSX, INSR, GHRH, COMT) and for 14 genes whose
expression is affected by the AAM-associated SNPs according to the
eQTL analysis (DNAJC27, STON1-GTF2A1L, LSAMP, RP11-384F7.2,
LINC00577, HACE1, TRIM66, CTB-133G6.2, MROH8, MANBAL, ARVCF,
SLC44A1, STK33, COMT). STK33 and COMT are present in both lists.
The information about six of these (STON1-GTF2A1L, RP11-384F7.2,
LINC00577, CTB-133G6.2) was not available in the Gene Ontology
databases.
According to the PANTHER protein class and PANTHER molecular
function databases, neuropeptide coding genes (Fold Enrichment –
97.23, pbonf= 0.039) and neuropeptide hormone activity (Fold
Enrichment -> 100.00, pbonf= 0.032), respectively, are over-
represented in the above-mentioned list of genes.
Using GeneMANIA (http://genemania.org), a network of the gene-
gene interactions between 15 AAM-associated genes and 20 other genes
was inferred (Fig. 3). These gene-gene interactions are realized through
co-expression (62.57%), co-localization (30.04%), genetic interactions
(5.61%), and common protein domains (1.79%). The gene-gene inter-
actions of the AAM-associated genes may be either direct or via inter-
mediate genes (e.g., USP49, SMARCA2) (Ponomarenko et al., 2018b).
4. Discussion
This study reports 14 loci associated with AAM in women of Russia.
Polymorphism rs6438424 located in region 3q13.32 demonstrated the
most significant association; its polymorphic allele C was associated
with later menarche according to the additive and dominant models,
whereas reference allele A was associated with early menarche. The
latter is in support of the previously reported results (Elks et al., 2010;
Delahanty et al., 2013). Elks et al. (Elks et al., 2010) also suggested
contribution of this SNP to height based on the GIANT consortium data.
Oh et al. (Oh et al., 2016) reported association of rs6438424 with the
breast tissue development.
According to the GTExportal database, polymorphism rs6438424
and eight polymorphisms linked to it have the cis-eQTL value and may
affect expression of RP11-384F7.2 and LSAMP in the adrenal glands and
visceral fat tissue. The RP11-384F7.2 gene belongs to the genes con-
trolling synthesis of long non-coding RNAs (lncRNAs) (http://www.
ensembl.org/), which contribute to numerous processes: histone mod-
ification, DNA methylation, chromatin remodeling, and the others,
which are important for embryonic development, reproduction, and
oncogenesis (Schmitz et al., 2016). LSAMP (limbic system-associated
membrane protein) encodes a protein of the immunoglobulin LAMP,
OBCAM and neurotrimin (IgLON) family. The LSAMP protein mediates
selective growth of neurons and axon targeting, and contributes to the
axon developing and remodeling of the limbic system. (http://www.
genecards.org/).
According to the results, locus rs7579411 of LHCGR was present in
the largest number of the most significant models of gene-gene inter-
actions associated with AAM (seven out of twelve). Another LHCGR
polymorphism, rs4374421, was involved in the two models. The asso-
ciation of these polymorphisms with AAM was previously reported by
He et al. (He et al., 2010). In the present study, rs7579411 was also
associated with height, and rs4374421 with BMI (involved in 10 models
of gene-gene interactions). The GTExportal database suggests that
rs7579411 may be associated with the expression of the STON1-
GTF2A1L gene in the thyroid gland.
The LHCGR gene encodes a receptor for luteinizing hormone (LH)
and gonadotropin (http://www.genecards.org/). LH produces multiple
effects on the female organism during prepuberty and puberty: induces
follicle development and androgen synthesis in the ovaries, initiates
ovulation and menarche, and the others (Abreu and Kaiser, 2016; Plant,
2015).
Polymorphism rs1073768 of the GHRH gene was involved in the
largest number of gene-gene interaction models (6 out of 12) associated
with AAM and was associated with height and BMI. The HaploReg
(v4.1) database suggests that rs1073768 has a significant regulatory
potential: it contains an enhancer histone mark in various cell types.
The significant association of rs1073768 with AAM was previously re-
ported by He et al. (He et al., 2010). The GHRH (growth hormone-re-
leasing hormone) gene controls release of the growth hormone, which
has a profound effect in the pubertal age. The GHRH and GH levels are
inversely related to BMI, accumulation of visceral fat, obesity, and
metabolic disorders (Stanley and Grinspoon, 2015).
Three polymorphisms of the LIN28B gene (rs7759938, rs314276,
rs4946651) were presented in 6 out of 12 most significant models of
gene-gene interactions. All these polymorphisms were previously re-
ported for their association with AAM: rs7759938 (Perry et al., 2009;
Elks et al., 2010; Perry et al., 2014; Delahanty et al., 2013), rs314276
(Ong et al., 2009), and rs4946651 (He et al., 2009). There are data
suggesting that rs7759938 and rs314276 may contribute to the pubertal
development and height (Ong et al., 2009; Perry et al., 2014; Lango
Allen et al., 2010; Cousminer et al., 2014). Ong et al. (Ong et al., 2011)
reported association of rs314276 with BMI and weight in females, but
not in males.
The GTExportal data suggest that the AAM-associated polymorph-
isms of LIN28B have important cis-eQTL values: rs4946651 and 14
linked to it are associated with transcription level of LINC00577 in the
basal ganglia, rs7759938 and rs314276 and 12 linked to them SNPs
may affect expression of the HACE1 gene in the EBV-transformed
lymphocytes.
LIN28B (lin-28 homolog B) encodes a protein of the LIN28 family,
which represses the let-7 family of miRNA (Tsialikas and Romer-Seibert,
2015). There are data that the let-7 miRNAs are involved in cell cycle
control and oncogenesis (Tsialikas and Romer-Seibert, 2015). The tar-
gets of the let-7 miRNA, Myc, Kras, Igf2bp1 and Hmga2, control body
size and metabolism in mammals (Zhu et al., 2011).
This study firstly reports two SNPs, rs4633 COMT and rs2252673
INSR, as possible contributors to AAM (through gene-gene interac-
tions). In addition, rs4633 manifested significant association with
height and BMI (through gene-gene interactions). Three SNPs, rs4680,
rs165656, and rs165722, which were in strong LD with rs4633, mani-
fested significant regulatory effects: all influenced expression of ARVCF
in the thyroid gland. The rs4633 and rs4680 polymorphisms are asso-
ciated with the COMT expression level in peripheral blood. The rs4680
polymorphism encodes a replacement substitution Val/Met in COMT
and according to the SIFT database has predictive value “deleterious”
(SIFT Score≤ 0.05): the Met variant has 40% lower activity as com-
pared to the Val one (Chen et al., 2004). Moreover, rs4680 is associated
with the level of some metabolites in blood (e.g., X-11593-O-methy-
lascorbate, X-01911, (Shin et al., 2014)). COMT (catechol-O-methyl-
transferase) is an enzyme, which participates in the metabolism of ca-
techolamines and estrogens (Sannino et al., 2017). Polymorphism
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rs2252673 of INSR, which was associated with AAM in the present
study, was previously associated with polycystic ovary syndrome
(Goodarzi et al., 2011).
5. Conclusions
The rs6438424 polymorphism is independently associated with
AAM in Russian females in this study. The other 14 SNPs manifest this
association through gene-gene interactions. The extensive in silico
analysis suggested that these associations might have more pronounced
effect through about 300 SNPs linked to the above polymorphisms and
implicated in multiple regulatory mechanisms in menarche-related or-
gans and tissues.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.gene.2018.11.042.
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